5-chloro-2-methyl-4-isothiazolin-3-one has been researched along with Vulvar Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brady, KL; Brady, SP; Clark, NS; Foote, CA; Mercurio, MG | 1 |
| Goldsmith, P; Nasir, S | 1 |
2 other study(ies) available for 5-chloro-2-methyl-4-isothiazolin-3-one and Vulvar Diseases
| Article | Year |
|---|---|
Vulvar dermatitis from allergy to moist flushable wipes.
Topics: Allergens; Anti-Inflammatory Agents; Dermatitis, Allergic Contact; Female; Humans; Middle Aged; Steroids; Thiazoles; Treatment Outcome; Vulva; Vulvar Diseases | 2014 |
Anogenital allergic contact dermatitis caused by methylchloroisothiazolinone, methylisothiazolinone and topical clotrimazole with subsequent generalized exanthem triggered by oral fluconazole.
Topics: Adult; Antifungal Agents; Anus Diseases; Clotrimazole; Dermatitis, Allergic Contact; Drug Eruptions; Female; Fluconazole; Humans; Patch Tests; Preservatives, Pharmaceutical; Thiazoles; Vulvar Diseases | 2016 |